FDA's Foreign Drug Manufacturing Inspection Process
The Senate Finance Committee held a hearing with drug manufacturers and Food and Drug Administration officials on the agency’s foreign drug … read more
The Senate Finance Committee held a hearing with drug manufacturers and Food and Drug Administration officials on the agency’s foreign drug manufacturing inspection process. The witnesses discussed vulnerabilities the supply chain faces with foreign markets, the important of surprise inspections on foreign manufacturers, and the how the COVID-19 pandemic had highlighted the need to manufacture more critical pharmaceuticals in the United States. They also addressed how the needs associated with the pandemic have provided further stress and challenges to the current U.S. drug supply. close
People in this video
-
Judith McMeekin Associate Commissioner
-
Doug Throckmorton M.D. Deputy Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
- Martin Van Trieste President and CEO Civica RX
Hosting Organization
Related Video
-
Labor Secretary Scalia Testiimony on Economic Impact of COVID-19
Labor Secretary Eugene Scaliahe testified at a Senate Finance Committee hearing about the impact of the coronavirus pand…
-
Senate Hearing on COVID-19 and the IRS
Internal Revenue Service (IRS) Commissioner Charles Rettig testified before the Senate Finance Committee about the impac…
-
Senate Finance Committee Hearing on Substance Abuse
Surgeon General Dr. Jerome Adams testified on substance abuse treatment before the Senate Finance Committee. Dr. Adams o…
-
Senate Majority Leader Schumer on Coronavirus Pandemic Economic Relief
Senate Majority Leader Chuck Schumer (D-NY) and several committee chairs held a news conference on coronavirus pandemic …